DB06643The risk or severity of adverse effects can be increased when Denosumab is combined with Fluocortolone.
DB00005The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocortolone.
DB00008The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocortolone.
DB00011The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluocortolone.
DB00018The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluocortolone.
DB00022The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluocortolone.
DB00026The risk or severity of adverse effects can be increased when Anakinra is combined with Fluocortolone.
DB00033The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluocortolone.
DB00034The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluocortolone.
DB00051The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluocortolone.
DB00056The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluocortolone.
DB00059The risk or severity of adverse effects can be increased when Pegaspargase is combined with Fluocortolone.
DB00065The risk or severity of adverse effects can be increased when Infliximab is combined with Fluocortolone.
DB00068The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Fluocortolone.
DB00069The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Fluocortolone.
DB00073The risk or severity of adverse effects can be increased when Rituximab is combined with Fluocortolone.
DB00074The risk or severity of adverse effects can be increased when Basiliximab is combined with Fluocortolone.
DB00075The risk or severity of adverse effects can be increased when Muromonab is combined with Fluocortolone.
DB00078The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Fluocortolone.
DB00081The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluocortolone.
DB00087The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Fluocortolone.
DB00092The risk or severity of adverse effects can be increased when Alefacept is combined with Fluocortolone.
DB00095The risk or severity of adverse effects can be increased when Efalizumab is combined with Fluocortolone.
DB00098The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Fluocortolone.
DB00105The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Fluocortolone.
DB00111The risk or severity of adverse effects can be increased when Daclizumab is combined with Fluocortolone.
DB00112The risk or severity of adverse effects can be increased when Bevacizumab is combined with Fluocortolone.
DB00120The risk or severity of adverse effects can be increased when Phenylalanine is combined with Fluocortolone.
DB00180The risk or severity of adverse effects can be increased when Flunisolide is combined with Fluocortolone.
DB00242The risk or severity of adverse effects can be increased when Cladribine is combined with Fluocortolone.
DB00262The risk or severity of adverse effects can be increased when Carmustine is combined with Fluocortolone.
DB00276The risk or severity of adverse effects can be increased when Amsacrine is combined with Fluocortolone.
DB00290The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluocortolone.
DB00291The risk or severity of adverse effects can be increased when Chlorambucil is combined with Fluocortolone.
DB00293The risk or severity of adverse effects can be increased when Raltitrexed is combined with Fluocortolone.
DB00305The risk or severity of adverse effects can be increased when Mitomycin is combined with Fluocortolone.
DB00307The risk or severity of adverse effects can be increased when Bexarotene is combined with Fluocortolone.
DB00322The risk or severity of adverse effects can be increased when Floxuridine is combined with Fluocortolone.
DB00352The risk or severity of adverse effects can be increased when Tioguanine is combined with Fluocortolone.
DB00380The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Fluocortolone.
DB00394The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Fluocortolone.
DB00428The risk or severity of adverse effects can be increased when Streptozocin is combined with Fluocortolone.
DB00432The risk or severity of adverse effects can be increased when Trifluridine is combined with Fluocortolone.
DB00441The risk or severity of adverse effects can be increased when Gemcitabine is combined with Fluocortolone.
DB00443The risk or severity of adverse effects can be increased when Betamethasone is combined with Fluocortolone.
DB00445The risk or severity of adverse effects can be increased when Epirubicin is combined with Fluocortolone.
DB00446The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluocortolone.
DB00480The risk or severity of adverse effects can be increased when Lenalidomide is combined with Fluocortolone.
DB00488The risk or severity of adverse effects can be increased when Altretamine is combined with Fluocortolone.
DB00495The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluocortolone.
DB00526The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Fluocortolone.
DB00544The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fluocortolone.
DB00547The risk or severity of adverse effects can be increased when Desoximetasone is combined with Fluocortolone.
DB00550The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Fluocortolone.
DB00552The risk or severity of adverse effects can be increased when Pentostatin is combined with Fluocortolone.
DB00588The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fluocortolone.
DB00591The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Fluocortolone.
DB00601The risk or severity of adverse effects can be increased when Linezolid is combined with Fluocortolone.
DB00620The risk or severity of adverse effects can be increased when Triamcinolone is combined with Fluocortolone.
DB00631The risk or severity of adverse effects can be increased when Clofarabine is combined with Fluocortolone.
DB00635The risk or severity of adverse effects can be increased when Prednisone is combined with Fluocortolone.
DB00642The risk or severity of adverse effects can be increased when Pemetrexed is combined with Fluocortolone.
DB00687The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Fluocortolone.
DB00688The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Fluocortolone.
DB00694The risk or severity of adverse effects can be increased when Daunorubicin is combined with Fluocortolone.
DB00755The risk or severity of adverse effects can be increased when Tretinoin is combined with Fluocortolone.
DB00763The risk or severity of adverse effects can be increased when Methimazole is combined with Fluocortolone.
DB00764The risk or severity of adverse effects can be increased when Mometasone is combined with Fluocortolone.
DB00851The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fluocortolone.
DB00853The risk or severity of adverse effects can be increased when Temozolomide is combined with Fluocortolone.
DB00859The risk or severity of adverse effects can be increased when Penicillamine is combined with Fluocortolone.
DB00860The risk or severity of adverse effects can be increased when Prednisolone is combined with Fluocortolone.
DB00928The risk or severity of adverse effects can be increased when Azacitidine is combined with Fluocortolone.
DB00958The risk or severity of adverse effects can be increased when Carboplatin is combined with Fluocortolone.
DB00959The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Fluocortolone.
DB00970The risk or severity of adverse effects can be increased when Dactinomycin is combined with Fluocortolone.
DB00987The risk or severity of adverse effects can be increased when Cytarabine is combined with Fluocortolone.
DB00993The risk or severity of adverse effects can be increased when Azathioprine is combined with Fluocortolone.
DB01005The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Fluocortolone.
DB01013The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Fluocortolone.
DB01024The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Fluocortolone.
DB01030The risk or severity of adverse effects can be increased when Topotecan is combined with Fluocortolone.
DB01033The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Fluocortolone.
DB01041The risk or severity of adverse effects can be increased when Thalidomide is combined with Fluocortolone.
DB01042The risk or severity of adverse effects can be increased when Melphalan is combined with Fluocortolone.
DB01047The risk or severity of adverse effects can be increased when Fluocinonide is combined with Fluocortolone.
DB01073The risk or severity of adverse effects can be increased when Fludarabine is combined with Fluocortolone.
DB01099The risk or severity of adverse effects can be increased when Flucytosine is combined with Fluocortolone.
DB01101The risk or severity of adverse effects can be increased when Capecitabine is combined with Fluocortolone.
DB01168The risk or severity of adverse effects can be increased when Procarbazine is combined with Fluocortolone.
DB01169The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Fluocortolone.
DB01177The risk or severity of adverse effects can be increased when Idarubicin is combined with Fluocortolone.
DB01196The risk or severity of adverse effects can be increased when Estramustine is combined with Fluocortolone.
DB01204The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluocortolone.
DB01206The risk or severity of adverse effects can be increased when Lomustine is combined with Fluocortolone.
DB01222The risk or severity of adverse effects can be increased when Budesonide is combined with Fluocortolone.
DB01234The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluocortolone.
DB01257The risk or severity of adverse effects can be increased when Eculizumab is combined with Fluocortolone.
DB01262The risk or severity of adverse effects can be increased when Decitabine is combined with Fluocortolone.
DB01280The risk or severity of adverse effects can be increased when Nelarabine is combined with Fluocortolone.
DB01281The risk or severity of adverse effects can be increased when Abatacept is combined with Fluocortolone.
DB01285The risk or severity of adverse effects can be increased when Corticotropin is combined with Fluocortolone.
DB01380The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Fluocortolone.
DB01384The risk or severity of adverse effects can be increased when Paramethasone is combined with Fluocortolone.
DB01394The risk or severity of adverse effects can be increased when Colchicine is combined with Fluocortolone.
DB01410The risk or severity of adverse effects can be increased when Ciclesonide is combined with Fluocortolone.
DB01423The risk or severity of adverse effects can be increased when Stepronin is combined with Fluocortolone.
DB01611The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Fluocortolone.
DB01816The risk or severity of adverse effects can be increased when Castanospermine is combined with Fluocortolone.
DB02546The risk or severity of adverse effects can be increased when Vorinostat is combined with Fluocortolone.
DB02806The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Fluocortolone.
DB03523The risk or severity of adverse effects can be increased when Brequinar is combined with Fluocortolone.
DB04630The risk or severity of adverse effects can be increased when Aldosterone is combined with Fluocortolone.
DB04951The risk or severity of adverse effects can be increased when Pirfenidone is combined with Fluocortolone.
DB04956The risk or severity of adverse effects can be increased when Afelimomab is combined with Fluocortolone.
DB05015The risk or severity of adverse effects can be increased when Belinostat is combined with Fluocortolone.
DB05258The risk or severity of adverse effects can be increased when Interferon alfa is combined with Fluocortolone.
DB05259The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluocortolone.
DB05260The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Fluocortolone.
DB05459The risk or severity of adverse effects can be increased when Briakinumab is combined with Fluocortolone.
DB05472The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Fluocortolone.
DB05676The risk or severity of adverse effects can be increased when Apremilast is combined with Fluocortolone.
DB06168The risk or severity of adverse effects can be increased when Canakinumab is combined with Fluocortolone.
DB06273The risk or severity of adverse effects can be increased when Tocilizumab is combined with Fluocortolone.
DB06372The risk or severity of adverse effects can be increased when Rilonacept is combined with Fluocortolone.
DB06612The risk or severity of adverse effects can be increased when Mepolizumab is combined with Fluocortolone.
DB06662The risk or severity of adverse effects can be increased when Abetimus is combined with Fluocortolone.
DB06674The risk or severity of adverse effects can be increased when Golimumab is combined with Fluocortolone.
DB06681The risk or severity of adverse effects can be increased when Belatacept is combined with Fluocortolone.
DB06769The risk or severity of adverse effects can be increased when Bendamustine is combined with Fluocortolone.
DB06813The risk or severity of adverse effects can be increased when Pralatrexate is combined with Fluocortolone.
DB08059The risk or severity of adverse effects can be increased when Wortmannin is combined with Fluocortolone.
DB08871The risk or severity of adverse effects can be increased when Eribulin is combined with Fluocortolone.
DB08879The risk or severity of adverse effects can be increased when Belimumab is combined with Fluocortolone.
DB08880The risk or severity of adverse effects can be increased when Teriflunomide is combined with Fluocortolone.
DB08889The risk or severity of adverse effects can be increased when Carfilzomib is combined with Fluocortolone.
DB08904The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Fluocortolone.
DB08906The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluocortolone.
DB08908The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Fluocortolone.
DB08935The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Fluocortolone.
DB08970The risk or severity of adverse effects can be increased when Fluprednidene is combined with Fluocortolone.
DB09029The risk or severity of adverse effects can be increased when Fluocortolone is combined with Secukinumab.
DB09033The risk or severity of adverse effects can be increased when Fluocortolone is combined with Vedolizumab.
DB09036The risk or severity of adverse effects can be increased when Fluocortolone is combined with Siltuximab.
DB09052The risk or severity of adverse effects can be increased when Fluocortolone is combined with Blinatumomab.
DB09077The risk or severity of adverse effects can be increased when Fluocortolone is combined with Dinutuximab.
DB09082The risk or severity of adverse effects can be increased when Fluocortolone is combined with Vilanterol.
DB09091The risk or severity of adverse effects can be increased when Fluocortolone is combined with Tixocortol.
DB09122The risk or severity of adverse effects can be increased when Fluocortolone is combined with Peginterferon beta-1a.
DB09312The risk or severity of adverse effects can be increased when Fluocortolone is combined with Antilymphocyte immunoglobulin (horse).
DB09378The risk or severity of adverse effects can be increased when Fluocortolone is combined with Fluprednisolone.
DB09383The risk or severity of adverse effects can be increased when Fluocortolone is combined with Meprednisone.
DB11487The risk or severity of adverse effects can be increased when Fluocortolone is combined with Dexamethasone isonicotinate.
DB11529The risk or severity of adverse effects can be increased when Fluocortolone is combined with Melengestrol.
DB11569The risk or severity of adverse effects can be increased when Fluocortolone is combined with Ixekizumab.
DB11580The risk or severity of adverse effects can be increased when Fluocortolone is combined with Ravulizumab.
DB11616The risk or severity of adverse effects can be increased when Fluocortolone is combined with Pirarubicin.
DB11693The risk or severity of adverse effects can be increased when Fluocortolone is combined with Voclosporin.
DB11708The risk or severity of adverse effects can be increased when Fluocortolone is combined with Peficitinib.
DB11750The risk or severity of adverse effects can be increased when Fluocortolone is combined with Clobetasol.
DB11767The risk or severity of adverse effects can be increased when Fluocortolone is combined with Sarilumab.
DB11776The risk or severity of adverse effects can be increased when Fluocortolone is combined with Brodalumab.
DB11803The risk or severity of adverse effects can be increased when Fluocortolone is combined with Sirukumab.
DB11834The risk or severity of adverse effects can be increased when Fluocortolone is combined with Guselkumab.
DB11921The risk or severity of adverse effects can be increased when Fluocortolone is combined with Deflazacort.
DB11988The risk or severity of adverse effects can be increased when Fluocortolone is combined with Ocrelizumab.
DB12612The risk or severity of adverse effects can be increased when Fluocortolone is combined with Ozanimod.
DB12617The risk or severity of adverse effects can be increased when Fluocortolone is combined with Mizoribine.
DB12692The risk or severity of adverse effects can be increased when Fluocortolone is combined with Gusperimus.
DB12814The risk or severity of adverse effects can be increased when Fluocortolone is combined with Cepeginterferon alfa-2B.
DB12902The risk or severity of adverse effects can be increased when Fluocortolone is combined with Trofosfamide.
DB12947The risk or severity of adverse effects can be increased when Fluocortolone is combined with Doxifluridine.
DB12991The risk or severity of adverse effects can be increased when Fluocortolone is combined with Deoxyspergualin.
DB12996The risk or severity of adverse effects can be increased when Fluocortolone is combined with Acteoside.
DB13003The risk or severity of adverse effects can be increased when Fluocortolone is combined with Cortivazol.
DB13014The risk or severity of adverse effects can be increased when Fluocortolone is combined with Hypericin.
DB13068The risk or severity of adverse effects can be increased when Fluocortolone is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
DB13208The risk or severity of adverse effects can be increased when Fluocortolone is combined with Prednylidene.
DB13223The risk or severity of adverse effects can be increased when Fluocortolone is combined with Fluocortin.
DB13241The risk or severity of adverse effects can be increased when Fluocortolone is combined with Begelomab.
DB13491The risk or severity of adverse effects can be increased when Fluocortolone is combined with Fluperolone.
DB13843The risk or severity of adverse effects can be increased when Fluocortolone is combined with Cloprednol.
DB13856The risk or severity of adverse effects can be increased when Fluocortolone is combined with Fluclorolone.
DB13867The risk or severity of adverse effects can be increased when Fluocortolone is combined with Fluticasone.
DB14066The risk or severity of adverse effects can be increased when Fluocortolone is combined with Tetrandrine.
DB14219The risk or severity of adverse effects can be increased when Fluocortolone is combined with Monomethyl fumarate.
DB14512The risk or severity of adverse effects can be increased when Fluocortolone is combined with Mometasone furoate.
DB14539The risk or severity of adverse effects can be increased when Fluocortolone is combined with Hydrocortisone acetate.
DB14540The risk or severity of adverse effects can be increased when Fluocortolone is combined with Hydrocortisone butyrate.
DB14545The risk or severity of adverse effects can be increased when Fluocortolone is combined with Hydrocortisone succinate.
DB14724The risk or severity of adverse effects can be increased when Fluocortolone is combined with Emapalumab.
DB14762The risk or severity of adverse effects can be increased when Fluocortolone is combined with Risankizumab.
DB14919The risk or severity of adverse effects can be increased when Fluocortolone is combined with Rozanolixizumab.
DB15253The risk or severity of adverse effects can be increased when Fluocortolone is combined with Bleselumab.
DB00619The risk or severity of adverse effects can be increased when Fluocortolone is combined with Imatinib.
DB09053The risk or severity of adverse effects can be increased when Fluocortolone is combined with Ibrutinib.
DB00324The risk or severity of adverse effects can be increased when Fluorometholone is combined with Fluocortolone.
DB09095The risk or severity of adverse effects can be increased when Fluocortolone is combined with Difluocortolone.
DB00108The risk or severity of adverse effects can be increased when Natalizumab is combined with Fluocortolone.
DB00337The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluocortolone.
DB01656Roflumilast may increase the immunosuppressive activities of Fluocortolone.
DB06688The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Fluocortolone.
DB09063The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Ceritinib.
DB00041The therapeutic efficacy of Fluocortolone can be decreased when used in combination with Aldesleukin.
DB09067The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluocortolone.
DB01609The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Fluocortolone is combined with Deferasirox.
DB00681The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Amphotericin B.
DB00221The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Isoetharine.
DB00368The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Norepinephrine.
DB00397The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Phenylpropanolamine.
DB00668The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Epinephrine.
DB00816The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Orciprenaline.
DB00841The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Dobutamine.
DB00867The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Ritodrine.
DB00901The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Bitolterol.
DB00938The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Salmeterol.
DB00983The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Formoterol.
DB01001The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Salbutamol.
DB01064The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Isoprenaline.
DB01102The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Arbutamine.
DB01274The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Arformoterol.
DB01288The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Fenoterol.
DB01291The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Pirbuterol.
DB01363The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Ephedra sinica root.
DB01366The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Procaterol.
DB01407The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Clenbuterol.
DB04846The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Celiprolol.
DB05039The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Indacaterol.
DB06262The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Droxidopa.
DB06814The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Protokylol.
DB08957The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Hexoprenaline.
DB09080The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Olodaterol.
DB09273The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Doxofylline.
DB11124The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Racepinephrine.
DB11587The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Etafedrine.
DB11871The risk or severity of hypokalemia can be increased when Fluocortolone is combined with PF-00610355.
DB12100The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Abediterol.
DB12526The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Batefenterol.
DB13139The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Levosalbutamol.
DB00834The therapeutic efficacy of Mifepristone can be decreased when used in combination with Fluocortolone.
DB00648The serum concentration of Fluocortolone can be decreased when it is combined with Mitotane.
DB00266Fluocortolone may increase the anticoagulant activities of Dicoumarol.
DB00498Fluocortolone may increase the anticoagulant activities of Phenindione.
DB00682Fluocortolone may increase the anticoagulant activities of Warfarin.
DB00946Fluocortolone may increase the anticoagulant activities of Phenprocoumon.
DB01418Fluocortolone may increase the anticoagulant activities of Acenocoumarol.
DB03410Fluocortolone may increase the anticoagulant activities of 4-hydroxycoumarin.
DB04665Fluocortolone may increase the anticoagulant activities of Coumarin.
DB08496Fluocortolone may increase the anticoagulant activities of (R)-warfarin.
DB08794Fluocortolone may increase the anticoagulant activities of Ethyl biscoumacetate.
DB13136Fluocortolone may increase the anticoagulant activities of Fluindione.
DB13275Fluocortolone may increase the anticoagulant activities of Clorindione.
DB13347Fluocortolone may increase the anticoagulant activities of Diphenadione.
DB13451Fluocortolone may increase the anticoagulant activities of Tioclomarol.
DB14055Fluocortolone may increase the anticoagulant activities of (S)-Warfarin.
DB01015The risk or severity of myelosuppression can be increased when Fluocortolone is combined with Sulfamethoxazole.
DB01097The risk or severity of adverse effects can be increased when Leflunomide is combined with Fluocortolone.
DB08895Tofacitinib may increase the immunosuppressive activities of Fluocortolone.
DB00072Trastuzumab may increase the neutropenic activities of Fluocortolone.
DB08868Fingolimod may increase the immunosuppressive activities of Fluocortolone.
DB09220The risk or severity of ulceration can be increased when Fluocortolone is combined with Nicorandil.
DB00864Tacrolimus may increase the immunosuppressive activities of Fluocortolone.
DB00136The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluocortolone.
DB00146The therapeutic efficacy of Calcifediol can be decreased when used in combination with Fluocortolone.
DB00153The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Fluocortolone.
DB00169The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Fluocortolone.
DB00910The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluocortolone.
DB01070The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Fluocortolone.
DB01436The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Fluocortolone.
DB04258The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Fluocortolone.
DB04796The therapeutic efficacy of Inecalcitol can be decreased when used in combination with Fluocortolone.
DB04891The therapeutic efficacy of Becocalcidiol can be decreased when used in combination with Fluocortolone.
DB05295The therapeutic efficacy of Eldecalcitol can be decreased when used in combination with Fluocortolone.
DB06117The therapeutic efficacy of 1alpha,24S-Dihydroxyvitamin D2 can be decreased when used in combination with Fluocortolone.
DB06194The therapeutic efficacy of Elocalcitol can be decreased when used in combination with Fluocortolone.
DB06272The therapeutic efficacy of Maxacalcitol can be decreased when used in combination with Fluocortolone.
DB06410The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Fluocortolone.
DB11094The therapeutic efficacy of Vitamin D can be decreased when used in combination with Fluocortolone.
DB13097The therapeutic efficacy of 1alpha-Hydroxyvitamin D5 can be decreased when used in combination with Fluocortolone.
DB12025The serum concentration of Triptolide can be increased when it is combined with Fluocortolone.
DB00255The serum concentration of Fluocortolone can be increased when it is combined with Diethylstilbestrol.
DB00294The serum concentration of Fluocortolone can be increased when it is combined with Etonogestrel.
DB00304The serum concentration of Fluocortolone can be increased when it is combined with Desogestrel.
DB00351The serum concentration of Fluocortolone can be increased when it is combined with Megestrol acetate.
DB00367The serum concentration of Fluocortolone can be increased when it is combined with Levonorgestrel.
DB00396The serum concentration of Fluocortolone can be increased when it is combined with Progesterone.
DB00603The serum concentration of Fluocortolone can be increased when it is combined with Medroxyprogesterone acetate.
DB00717The serum concentration of Fluocortolone can be increased when it is combined with Norethisterone.
DB00783The serum concentration of Fluocortolone can be increased when it is combined with Estradiol.
DB00823The serum concentration of Fluocortolone can be increased when it is combined with Ethynodiol diacetate.
DB00957The serum concentration of Fluocortolone can be increased when it is combined with Norgestimate.
DB00977The serum concentration of Fluocortolone can be increased when it is combined with Ethinylestradiol.
DB01357The serum concentration of Fluocortolone can be increased when it is combined with Mestranol.
DB01395The serum concentration of Fluocortolone can be increased when it is combined with Drospirenone.
DB04066The serum concentration of Fluocortolone can be increased when it is combined with p-Coumaric acid.
DB04574The serum concentration of Fluocortolone can be increased when it is combined with Estrone sulfate.
DB04682The serum concentration of Fluocortolone can be increased when it is combined with Octylphenoxy polyethoxyethanol.
DB04839The serum concentration of Fluocortolone can be increased when it is combined with Cyproterone acetate.
DB05830The serum concentration of Fluocortolone can be increased when it is combined with Trestolone.
DB06266The serum concentration of Fluocortolone can be increased when it is combined with Lonidamine.
DB06713The serum concentration of Fluocortolone can be increased when it is combined with Norelgestromin.
DB06730The serum concentration of Fluocortolone can be increased when it is combined with Gestodene.
DB06789The serum concentration of Fluocortolone can be increased when it is combined with Hydroxyprogesterone caproate.
DB08867The serum concentration of Fluocortolone can be increased when it is combined with Ulipristal.
DB09123The serum concentration of Fluocortolone can be increased when it is combined with Dienogest.
DB09371The serum concentration of Fluocortolone can be increased when it is combined with Norethynodrel.
DB09389The serum concentration of Fluocortolone can be increased when it is combined with Norgestrel.
DB09401The serum concentration of Fluocortolone can be increased when it is combined with Isosorbide.
DB11507The serum concentration of Fluocortolone can be increased when it is combined with Cloprostenol.
DB11619The serum concentration of Fluocortolone can be increased when it is combined with Gestrinone.
DB11636The serum concentration of Fluocortolone can be increased when it is combined with Nomegestrol.
DB12474The serum concentration of Fluocortolone can be increased when it is combined with Lynestrenol.
DB13044The serum concentration of Fluocortolone can be increased when it is combined with Gossypol.
DB13310The serum concentration of Fluocortolone can be increased when it is combined with Ormeloxifene.
DB13528The serum concentration of Fluocortolone can be increased when it is combined with Chlormadinone.
DB13563The serum concentration of Fluocortolone can be increased when it is combined with Norgestrienone.
DB13685The serum concentration of Fluocortolone can be increased when it is combined with Quingestanol.
DB13857The serum concentration of Fluocortolone can be increased when it is combined with Demegestone.
DB13866The serum concentration of Fluocortolone can be increased when it is combined with Etynodiol.
DB13944The serum concentration of Fluocortolone can be increased when it is combined with Testosterone enanthate.
DB13953The serum concentration of Fluocortolone can be increased when it is combined with Estradiol benzoate.
DB13954The serum concentration of Fluocortolone can be increased when it is combined with Estradiol cypionate.
DB13956The serum concentration of Fluocortolone can be increased when it is combined with Estradiol valerate.
DB13981The serum concentration of Fluocortolone can be increased when it is combined with Nomegestrol acetate.
DB14678The serum concentration of Fluocortolone can be increased when it is combined with Norethindrone enanthate.
DB00218The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Moxifloxacin.
DB00365The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Grepafloxacin.
DB00467The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Enoxacin.
DB00487The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Pefloxacin.
DB00537The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Ciprofloxacin.
DB00685The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Trovafloxacin.
DB00779The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Nalidixic acid.
DB00817The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Rosoxacin.
DB00827The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Cinoxacin.
DB00978The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Lomefloxacin.
DB01044The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Gatifloxacin.
DB01059The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Norfloxacin.
DB01137The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Levofloxacin.
DB01155The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Gemifloxacin.
DB01165The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Ofloxacin.
DB01208The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Sparfloxacin.
DB01405The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Temafloxacin.
DB04576The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Fleroxacin.
DB05488The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Technetium Tc-99m ciprofloxacin.
DB06160The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Garenoxacin.
DB06600The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Nemonoxacin.
DB08972The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Flumequine.
DB11404The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Enrofloxacin.
DB11443The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Orbifloxacin.
DB11491The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Sarafloxacin.
DB11511The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Difloxacin.
DB11774The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Pazufloxacin.
DB11892The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Prulifloxacin.
DB11943The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Delafloxacin.
DB13261The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Sitafloxacin.
DB13627The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Oxolinic acid.
DB13772The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Rufloxacin.
DB13823The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Pipemidic acid.
DB00310Fluocortolone may increase the hypokalemic activities of Chlorthalidone.
DB00524Fluocortolone may increase the hypokalemic activities of Metolazone.
DB00808Fluocortolone may increase the hypokalemic activities of Indapamide.
DB01325Fluocortolone may increase the hypokalemic activities of Quinethazone.
DB13989Fluocortolone may increase the hypokalemic activities of Epitizide.
DB00621The risk or severity of fluid retention can be increased when Fluocortolone is combined with Oxandrolone.
DB01185The risk or severity of fluid retention can be increased when Fluocortolone is combined with Fluoxymesterone.
DB01406The risk or severity of fluid retention can be increased when Fluocortolone is combined with Danazol.
DB06412The risk or severity of fluid retention can be increased when Fluocortolone is combined with Oxymetholone.
DB06718The risk or severity of fluid retention can be increased when Fluocortolone is combined with Stanozolol.
DB12461The risk or severity of fluid retention can be increased when Fluocortolone is combined with GLPG-0492.
DB01377The bioavailability of Fluocortolone can be decreased when combined with Magnesium oxide.
DB01390The bioavailability of Fluocortolone can be decreased when combined with Sodium bicarbonate.
DB06723The bioavailability of Fluocortolone can be decreased when combined with Aluminum hydroxide.
DB06724The bioavailability of Fluocortolone can be decreased when combined with Calcium carbonate.
DB08938The bioavailability of Fluocortolone can be decreased when combined with Magaldrate.
DB09104The bioavailability of Fluocortolone can be decreased when combined with Magnesium hydroxide.
DB09281The bioavailability of Fluocortolone can be decreased when combined with Magnesium trisilicate.
DB09481The bioavailability of Fluocortolone can be decreased when combined with Magnesium carbonate.
DB13249The bioavailability of Fluocortolone can be decreased when combined with Magnesium silicate.
DB13280The bioavailability of Fluocortolone can be decreased when combined with Aluminium acetoacetate.
DB13322The bioavailability of Fluocortolone can be decreased when combined with Hydrotalcite.
DB13486The bioavailability of Fluocortolone can be decreased when combined with Magnesium peroxide.
DB13595The bioavailability of Fluocortolone can be decreased when combined with Almasilate.
DB13626The bioavailability of Fluocortolone can be decreased when combined with Aluminium glycinate.
DB13650The bioavailability of Fluocortolone can be decreased when combined with Aloglutamol.
DB13829The bioavailability of Fluocortolone can be decreased when combined with Calcium silicate.
DB14517The bioavailability of Fluocortolone can be decreased when combined with Aluminium phosphate.
DB00214The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Torasemide.
DB00695The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Furosemide.
DB00887The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Bumetanide.
DB00903The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Etacrynic acid.
DB02925The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Piretanide.
DB08961The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Azosemide.
DB00328The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Fluocortolone.
DB00795The risk or severity of gastrointestinal irritation can be increased when Sulfasalazine is combined with Fluocortolone.
DB11466The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Tepoxalin.
DB00159The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Icosapent.
DB00244The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Mesalazine.
DB00461The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Nabumetone.
DB00465The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Ketorolac.
DB00469The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Tenoxicam.
DB00482The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Celecoxib.
DB00500The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Tolmetin.
DB00533The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Rofecoxib.
DB00554The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Piroxicam.
DB00573The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Fenoprofen.
DB00580The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Valdecoxib.
DB00586The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Diclofenac.
DB00605The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Sulindac.
DB00712The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Flurbiprofen.
DB00749The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Etodolac.
DB00784The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Mefenamic acid.
DB00788The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Naproxen.
DB00812The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Phenylbutazone.
DB00814The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Meloxicam.
DB00821The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Carprofen.
DB00861The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Diflunisal.
DB00936The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Salicylic acid.
DB00939The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Meclofenamic acid.
DB00991The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Oxaprozin.
DB01009The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Ketoprofen.
DB01014The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Balsalazide.
DB01050The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Ibuprofen.
DB01250The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Olsalazine.
DB01283The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Lumiracoxib.
DB01397The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Magnesium salicylate.
DB01399The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Salsalate.
DB01401The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Choline magnesium trisalicylate.
DB01419The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Antrafenine.
DB01424The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Aminophenazone.
DB01435The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Antipyrine.
DB01600The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Tiaprofenic acid.
DB01628The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Etoricoxib.
DB02224The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Taxifolin.
DB03585The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Oxyphenbutazone.
DB04725The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Licofelone.
DB04743The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Nimesulide.
DB04812The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Benoxaprofen.
DB04817The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Metamizole.
DB04828The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Zomepirac.
DB05095The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Cimicoxib.
DB06725The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Lornoxicam.
DB06736The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Aceclofenac.
DB06737The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Zaltoprofen.
DB07402The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Azapropazone.
DB08439The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Parecoxib.
DB08797The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Salicylamide.
DB08940The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Kebuzone.
DB08942The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Isoxicam.
DB08951The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Indoprofen.
DB08955The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Ibuproxam.
DB08976The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Floctafenine.
DB08981The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Fenbufen.
DB08984The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Etofenamate.
DB08991The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Epirizole.
DB09084The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Benzydamine.
DB09212The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Loxoprofen.
DB09213The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Dexibuprofen.
DB09214The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Dexketoprofen.
DB09215The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Droxicam.
DB09216The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Tolfenamic acid.
DB09217The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Firocoxib.
DB09218The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Clonixin.
DB09285The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Morniflumate.
DB09288The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Propacetamol.
DB09295The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Talniflumate.
DB11455The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Robenacoxib.
DB11518The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Flunixin.
DB12399The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Polmacoxib.
DB12445The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Nitroaspirin.
DB12545The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Indobufen.
DB12610The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Ebselen.
DB13001The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Tinoridine.
DB13167The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Alclofenac.
DB13217The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Fentiazac.
DB13232The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Suxibuzone.
DB13286The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Bumadizone.
DB13314The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Alminoprofen.
DB13371The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Difenpiramide.
DB13407The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Nifenazone.
DB13432The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Lonazolac.
DB13481The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Tenidap.
DB13524The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Propyphenazone.
DB13527The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Proglumetacin.
DB13538The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Guacetisal.
DB13544The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Ethenzamide.
DB13612The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Carbaspirin calcium.
DB13629The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Mofebutazone.
DB13649The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Proquazone.
DB13657The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Benorilate.
DB13722The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Pirprofen.
DB13783The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Acemetacin.
DB13860The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Imidazole salicylate.
DB14059The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with SC-236.
DB14060The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with NS-398.
DB14938The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Flurbiprofen axetil.
DB00515The therapeutic efficacy of Fluocortolone can be decreased when used in combination with Cisplatin.
DB00888The therapeutic efficacy of Fluocortolone can be decreased when used in combination with Mechlorethamine.
DB04572The therapeutic efficacy of Fluocortolone can be decreased when used in combination with Thiotepa.
DB00871The therapeutic efficacy of Terbutaline can be decreased when used in combination with Fluocortolone.
DB01408The therapeutic efficacy of Bambuterol can be decreased when used in combination with Fluocortolone.
DB00082The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Fluocortolone.
DB00358The therapeutic efficacy of Mefloquine can be decreased when used in combination with Fluocortolone.
DB00382The therapeutic efficacy of Tacrine can be decreased when used in combination with Fluocortolone.
DB00391The therapeutic efficacy of Sulpiride can be decreased when used in combination with Fluocortolone.
DB00392The therapeutic efficacy of Profenamine can be decreased when used in combination with Fluocortolone.
DB00477The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Fluocortolone.
DB00483The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Fluocortolone.
DB00508The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Fluocortolone.
DB00527The therapeutic efficacy of Cinchocaine can be decreased when used in combination with Fluocortolone.
DB00545The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Fluocortolone.
DB00585The therapeutic efficacy of Nizatidine can be decreased when used in combination with Fluocortolone.
DB00674The therapeutic efficacy of Galantamine can be decreased when used in combination with Fluocortolone.
DB00677The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Fluocortolone.
DB00711The therapeutic efficacy of Diethylcarbamazine can be decreased when used in combination with Fluocortolone.
DB00721The therapeutic efficacy of Procaine can be decreased when used in combination with Fluocortolone.
DB00805The therapeutic efficacy of Minaprine can be decreased when used in combination with Fluocortolone.
DB00843The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluocortolone.
DB00941The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Fluocortolone.
DB00944The therapeutic efficacy of Demecarium can be decreased when used in combination with Fluocortolone.
DB00981The therapeutic efficacy of Physostigmine can be decreased when used in combination with Fluocortolone.
DB00989The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Fluocortolone.
DB01010The therapeutic efficacy of Edrophonium can be decreased when used in combination with Fluocortolone.
DB01035The therapeutic efficacy of Procainamide can be decreased when used in combination with Fluocortolone.
DB01043The therapeutic efficacy of Memantine can be decreased when used in combination with Fluocortolone.
DB01122The therapeutic efficacy of Ambenonium can be decreased when used in combination with Fluocortolone.
DB01199The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Fluocortolone.
DB01221The therapeutic efficacy of Ketamine can be decreased when used in combination with Fluocortolone.
DB01233The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Fluocortolone.
DB01245The therapeutic efficacy of Decamethonium can be decreased when used in combination with Fluocortolone.
DB01337The therapeutic efficacy of Pancuronium can be decreased when used in combination with Fluocortolone.
DB01338The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Fluocortolone.
DB01381The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Fluocortolone.
DB01400The therapeutic efficacy of Neostigmine can be decreased when used in combination with Fluocortolone.
DB02365The therapeutic efficacy of 1,10-Phenanthroline can be decreased when used in combination with Fluocortolone.
DB02845The therapeutic efficacy of Methylphosphinic Acid can be decreased when used in combination with Fluocortolone.
DB04864The therapeutic efficacy of Huperzine A can be decreased when used in combination with Fluocortolone.
DB04892The therapeutic efficacy of Phenserine can be decreased when used in combination with Fluocortolone.
DB05386The therapeutic efficacy of Regramostim can be decreased when used in combination with Fluocortolone.
DB06692The therapeutic efficacy of Aprotinin can be decreased when used in combination with Fluocortolone.
DB06756The therapeutic efficacy of Glycine betaine can be decreased when used in combination with Fluocortolone.
DB06774The therapeutic efficacy of Capsaicin can be decreased when used in combination with Fluocortolone.
DB11390The therapeutic efficacy of Coumaphos can be decreased when used in combination with Fluocortolone.
DB11397The therapeutic efficacy of Dichlorvos can be decreased when used in combination with Fluocortolone.
DB11412The therapeutic efficacy of Fenthion can be decreased when used in combination with Fluocortolone.
DB11473The therapeutic efficacy of Metrifonate can be decreased when used in combination with Fluocortolone.
DB12482The therapeutic efficacy of Acotiamide can be decreased when used in combination with Fluocortolone.
DB13058The therapeutic efficacy of Methanesulfonyl Fluoride can be decreased when used in combination with Fluocortolone.
DB13495The therapeutic efficacy of Paraoxon can be decreased when used in combination with Fluocortolone.
DB13503The therapeutic efficacy of Tyrothricin can be decreased when used in combination with Fluocortolone.
DB13668The therapeutic efficacy of Ipidacrine can be decreased when used in combination with Fluocortolone.
DB13694The therapeutic efficacy of Distigmine can be decreased when used in combination with Fluocortolone.
DB14031The therapeutic efficacy of Tretamine can be decreased when used in combination with Fluocortolone.
DB15317The therapeutic efficacy of Posiphen can be decreased when used in combination with Fluocortolone.
DB00202The risk or severity of myopathy and weakness can be increased when Succinylcholine is combined with Fluocortolone.
DB00416The risk or severity of myopathy and weakness can be increased when Metocurine iodide is combined with Fluocortolone.
DB00565The risk or severity of myopathy and weakness can be increased when Cisatracurium is combined with Fluocortolone.
DB00728The risk or severity of myopathy and weakness can be increased when Rocuronium is combined with Fluocortolone.
DB00732The risk or severity of myopathy and weakness can be increased when Atracurium besylate is combined with Fluocortolone.
DB01135The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fluocortolone.
DB01226The risk or severity of myopathy and weakness can be increased when Mivacurium is combined with Fluocortolone.
DB01336The risk or severity of myopathy and weakness can be increased when Metocurine is combined with Fluocortolone.
DB01339The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Fluocortolone.
DB04834The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluocortolone.
DB11156The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Fluocortolone.
DB12989The risk or severity of myopathy and weakness can be increased when Neosaxitoxin is combined with Fluocortolone.
DB13295The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Fluocortolone.
DB13584The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Fluocortolone.
DB13648The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Fluocortolone.
DB03793The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Fluocortolone.
DB06819The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Fluocortolone.
DB08909The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Fluocortolone.
DB09269The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Fluocortolone.
DB01108The risk or severity of edema formation can be increased when Trilostane is combined with Fluocortolone.
DB00624The risk or severity of edema formation can be increased when Fluocortolone is combined with Testosterone.
DB00984The risk or severity of edema formation can be increased when Fluocortolone is combined with Nandrolone phenpropionate.
DB01420The risk or severity of edema formation can be increased when Fluocortolone is combined with Testosterone propionate.
DB06710The risk or severity of edema formation can be increased when Fluocortolone is combined with Methyltestosterone.
DB08804The risk or severity of edema formation can be increased when Fluocortolone is combined with Nandrolone decanoate.
DB13169The risk or severity of edema formation can be increased when Fluocortolone is combined with Nandrolone.
DB13587The risk or severity of edema formation can be increased when Fluocortolone is combined with Mesterolone.
DB13943The risk or severity of edema formation can be increased when Fluocortolone is combined with Testosterone cypionate.
DB13946The risk or severity of edema formation can be increased when Fluocortolone is combined with Testosterone undecanoate.
DB01434The risk or severity of edema formation can be increased when 19-norandrostenedione is combined with Fluocortolone.
DB01456The risk or severity of edema formation can be increased when 5-androstenedione is combined with Fluocortolone.
DB01471The risk or severity of edema formation can be increased when Bolasterone is combined with Fluocortolone.
DB01481The risk or severity of edema formation can be increased when 1-Testosterone is combined with Fluocortolone.
DB01485The risk or severity of edema formation can be increased when 4-Hydroxytestosterone is combined with Fluocortolone.
DB01521The risk or severity of edema formation can be increased when Clostebol is combined with Fluocortolone.
DB01524The risk or severity of edema formation can be increased when Androstenediol is combined with Fluocortolone.
DB01536The risk or severity of edema formation can be increased when Androstenedione is combined with Fluocortolone.
DB01541The risk or severity of edema formation can be increased when Boldenone is combined with Fluocortolone.
DB01554The risk or severity of edema formation can be increased when Bolandiol is combined with Fluocortolone.
DB01564The risk or severity of edema formation can be increased when Calusterone is combined with Fluocortolone.
DB05107The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Fluocortolone.
DB05804The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Fluocortolone.
DB06250The risk or severity of edema formation can be increased when Fluasterone is combined with Fluocortolone.
DB07768The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluocortolone.
DB08619The risk or severity of edema formation can be increased when Testosterone succinate is combined with Fluocortolone.
DB08905The risk or severity of edema formation can be increased when Formestane is combined with Fluocortolone.
DB11429The risk or severity of edema formation can be increased when Mibolerone is combined with Fluocortolone.
DB12194The risk or severity of edema formation can be increased when Atamestane is combined with Fluocortolone.
DB13710The risk or severity of edema formation can be increased when Metenolone is combined with Fluocortolone.
DB13947The risk or severity of edema formation can be increased when Testosterone enantate benzilic acid hydrazone is combined with Fluocortolone.
DB13958The risk or severity of edema formation can be increased when Trestolone acetate is combined with Fluocortolone.
DB11642The serum concentration of Fluocortolone can be decreased when it is combined with Pitolisant.
DB09046The metabolism of Fluocortolone can be increased when combined with Metreleptin.
DB00186The metabolism of Lorazepam can be increased when combined with Fluocortolone.
DB00191The metabolism of Phentermine can be increased when combined with Fluocortolone.
DB00207The metabolism of Azithromycin can be increased when combined with Fluocortolone.
DB00208The metabolism of Ticlopidine can be increased when combined with Fluocortolone.
DB00246The metabolism of Ziprasidone can be increased when combined with Fluocortolone.
DB00247The metabolism of Methysergide can be increased when combined with Fluocortolone.
DB00264The metabolism of Metoprolol can be increased when combined with Fluocortolone.
DB00426The metabolism of Famciclovir can be increased when combined with Fluocortolone.
DB00433The metabolism of Prochlorperazine can be increased when combined with Fluocortolone.
DB00454The metabolism of Meperidine can be increased when combined with Fluocortolone.
DB00476The metabolism of Duloxetine can be increased when combined with Fluocortolone.
DB00518The metabolism of Albendazole can be increased when combined with Fluocortolone.
DB00549The metabolism of Zafirlukast can be increased when combined with Fluocortolone.
DB00567The metabolism of Cephalexin can be increased when combined with Fluocortolone.
DB00590The metabolism of Doxazosin can be increased when combined with Fluocortolone.
DB01039The metabolism of Fenofibrate can be increased when combined with Fluocortolone.
DB01072The metabolism of Atazanavir can be increased when combined with Fluocortolone.
DB01098The metabolism of Rosuvastatin can be increased when combined with Fluocortolone.
DB01323The metabolism of St. John's Wort can be increased when combined with Fluocortolone.
DB01411The metabolism of Pranlukast can be increased when combined with Fluocortolone.
DB01431The metabolism of Allylestrenol can be increased when combined with Fluocortolone.
DB01624The metabolism of Zuclopenthixol can be increased when combined with Fluocortolone.
DB06201The metabolism of Rufinamide can be increased when combined with Fluocortolone.
DB06218The metabolism of Lacosamide can be increased when combined with Fluocortolone.
DB06480The metabolism of Prucalopride can be increased when combined with Fluocortolone.
DB06717The metabolism of Fosaprepitant can be increased when combined with Fluocortolone.
DB09030The metabolism of Vorapaxar can be increased when combined with Fluocortolone.
DB09034The metabolism of Suvorexant can be increased when combined with Fluocortolone.
DB09048The metabolism of Netupitant can be increased when combined with Fluocortolone.
DB09071The metabolism of Tasimelteon can be increased when combined with Fluocortolone.
DB09079The metabolism of Nintedanib can be increased when combined with Fluocortolone.
DB09299The metabolism of Tenofovir alafenamide can be increased when combined with Fluocortolone.
DB11273The metabolism of Dihydroergocornine can be increased when combined with Fluocortolone.
DB11730The metabolism of Ribociclib can be increased when combined with Fluocortolone.
DB11742The metabolism of Ebastine can be increased when combined with Fluocortolone.
DB11952The metabolism of Duvelisib can be increased when combined with Fluocortolone.
DB12141The metabolism of Gilteritinib can be increased when combined with Fluocortolone.
DB12515The metabolism of 9-aminocamptothecin can be increased when combined with Fluocortolone.
DB12825The metabolism of Lefamulin can be increased when combined with Fluocortolone.
DB12887The metabolism of Tazemetostat can be increased when combined with Fluocortolone.
DB12952The metabolism of Methylprednisone can be increased when combined with Fluocortolone.
DB13345The metabolism of Dihydroergocristine can be increased when combined with Fluocortolone.
DB13385The metabolism of Dihydroergocryptine can be increased when combined with Fluocortolone.
DB14009The metabolism of Medical Cannabis can be increased when combined with Fluocortolone.
DB14126The metabolism of Tenofovir can be increased when combined with Fluocortolone.
DB15444The metabolism of Elexacaftor can be increased when combined with Fluocortolone.
DB00342The metabolism of Terfenadine can be increased when combined with Fluocortolone.
DB00604The metabolism of Cisapride can be increased when combined with Fluocortolone.
DB11633The metabolism of Isavuconazole can be increased when combined with Fluocortolone.
DB00188The metabolism of Fluocortolone can be increased when combined with Bortezomib.
DB00309The metabolism of Fluocortolone can be increased when combined with Vindesine.
DB00361The metabolism of Fluocortolone can be increased when combined with Vinorelbine.
DB00398The metabolism of Fluocortolone can be increased when combined with Sorafenib.
DB00444The metabolism of Fluocortolone can be increased when combined with Teniposide.
DB00531The metabolism of Fluocortolone can be increased when combined with Cyclophosphamide.
DB00541The metabolism of Fluocortolone can be increased when combined with Vincristine.
DB00563The metabolism of Fluocortolone can be increased when combined with Methotrexate.
DB00564The metabolism of Fluocortolone can be increased when combined with Carbamazepine.
DB00570The metabolism of Fluocortolone can be increased when combined with Vinblastine.
DB00762The metabolism of Fluocortolone can be increased when combined with Irinotecan.
DB00773The metabolism of Fluocortolone can be increased when combined with Etoposide.
DB00877The metabolism of Fluocortolone can be increased when combined with Sirolimus.
DB00997The metabolism of Fluocortolone can be increased when combined with Doxorubicin.
DB01008The metabolism of Fluocortolone can be increased when combined with Busulfan.
DB01181The metabolism of Fluocortolone can be increased when combined with Ifosfamide.
DB01229The metabolism of Fluocortolone can be increased when combined with Paclitaxel.
DB01248The metabolism of Fluocortolone can be increased when combined with Docetaxel.
DB01254The metabolism of Fluocortolone can be increased when combined with Dasatinib.
DB01590The metabolism of Fluocortolone can be increased when combined with Everolimus.
DB04845The metabolism of Fluocortolone can be increased when combined with Ixabepilone.
DB04868The metabolism of Fluocortolone can be increased when combined with Nilotinib.
DB05109The metabolism of Fluocortolone can be increased when combined with Trabectedin.
DB05773The metabolism of Fluocortolone can be increased when combined with Trastuzumab emtansine.
DB06287The metabolism of Fluocortolone can be increased when combined with Temsirolimus.
DB06589The metabolism of Fluocortolone can be increased when combined with Pazopanib.
DB06603The metabolism of Fluocortolone can be increased when combined with Panobinostat.
DB06616The metabolism of Fluocortolone can be increased when combined with Bosutinib.
DB06772The metabolism of Fluocortolone can be increased when combined with Cabazitaxel.
DB08870The metabolism of Fluocortolone can be increased when combined with Brentuximab vedotin.
DB08877The metabolism of Fluocortolone can be increased when combined with Ruxolitinib.
DB08901The metabolism of Fluocortolone can be increased when combined with Ponatinib.
DB08910The metabolism of Fluocortolone can be increased when combined with Pomalidomide.
DB09054The metabolism of Idelalisib can be increased when combined with Fluocortolone.
DB09073The metabolism of Palbociclib can be increased when combined with Fluocortolone.
DB09074The metabolism of Olaparib can be increased when combined with Fluocortolone.
DB11817The metabolism of Baricitinib can be increased when combined with Fluocortolone.
DB12371The metabolism of Siponimod can be increased when combined with Fluocortolone.
DB00637The metabolism of Astemizole can be increased when combined with Fluocortolone.
DB01100The metabolism of Pimozide can be increased when combined with Fluocortolone.
DB01118The metabolism of Amiodarone can be increased when combined with Fluocortolone.
DB05239The metabolism of Cobimetinib can be increased when combined with Fluocortolone.
DB08827The metabolism of Lomitapide can be increased when combined with Fluocortolone.
DB09330The metabolism of Osimertinib can be increased when combined with Fluocortolone.
DB11963The metabolism of Dacomitinib can be increased when combined with Fluocortolone.
DB12015The metabolism of Alpelisib can be increased when combined with Fluocortolone.
DB00204The metabolism of Dofetilide can be increased when combined with Fluocortolone.
DB00248The metabolism of Cabergoline can be increased when combined with Fluocortolone.
DB00277The metabolism of Theophylline can be increased when combined with Fluocortolone.
DB00530The metabolism of Erlotinib can be increased when combined with Fluocortolone.
DB00675The metabolism of Tamoxifen can be increased when combined with Fluocortolone.
DB00908The metabolism of Quinidine can be increased when combined with Fluocortolone.
DB01223The metabolism of Aminophylline can be increased when combined with Fluocortolone.
DB04855The metabolism of Dronedarone can be increased when combined with Fluocortolone.
DB05294The metabolism of Vandetanib can be increased when combined with Fluocortolone.
DB06595The metabolism of Midostaurin can be increased when combined with Fluocortolone.
DB06626The metabolism of Axitinib can be increased when combined with Fluocortolone.
DB08865The metabolism of Crizotinib can be increased when combined with Fluocortolone.
DB08881The metabolism of Vemurafenib can be increased when combined with Fluocortolone.
DB08912The metabolism of Dabrafenib can be increased when combined with Fluocortolone.
DB09143The metabolism of Sonidegib can be increased when combined with Fluocortolone.
DB09289The metabolism of Tianeptine can be increased when combined with Fluocortolone.
DB09570The metabolism of Ixazomib can be increased when combined with Fluocortolone.
DB11363The metabolism of Alectinib can be increased when combined with Fluocortolone.
DB11581The metabolism of Venetoclax can be increased when combined with Fluocortolone.
DB11641The metabolism of Vinflunine can be increased when combined with Fluocortolone.
DB11703The metabolism of Acalabrutinib can be increased when combined with Fluocortolone.
DB11828The metabolism of Neratinib can be increased when combined with Fluocortolone.
DB12147The metabolism of Erdafitinib can be increased when combined with Fluocortolone.
DB12267The metabolism of Brigatinib can be increased when combined with Fluocortolone.
DB12483The metabolism of Copanlisib can be increased when combined with Fluocortolone.
DB12978The metabolism of Pexidartinib can be increased when combined with Fluocortolone.
DB13874The metabolism of Enasidenib can be increased when combined with Fluocortolone.
DB14568The metabolism of Ivosidenib can be increased when combined with Fluocortolone.
DB15035The metabolism of Zanubrutinib can be increased when combined with Fluocortolone.
DB00575The metabolism of Clonidine can be increased when combined with Fluocortolone.
DB06176The metabolism of Romidepsin can be increased when combined with Fluocortolone.
DB06212The metabolism of Tolvaptan can be increased when combined with Fluocortolone.
DB08896The metabolism of Regorafenib can be increased when combined with Fluocortolone.
DB12001The metabolism of Abemaciclib can be increased when combined with Fluocortolone.
DB00320The metabolism of Dihydroergotamine can be increased when combined with Fluocortolone.
DB00696The metabolism of Ergotamine can be increased when combined with Fluocortolone.
DB00872The metabolism of Conivaptan can be increased when combined with Fluocortolone.
DB01128The metabolism of Bicalutamide can be increased when combined with Fluocortolone.
DB01242The metabolism of Clomipramine can be increased when combined with Fluocortolone.
DB00540The metabolism of Nortriptyline can be increased when combined with Fluocortolone.
DB01227The metabolism of Levacetylmethadol can be increased when combined with Fluocortolone.
DB00199The metabolism of Erythromycin can be increased when combined with Fluocortolone.
DB00203The metabolism of Sildenafil can be increased when combined with Fluocortolone.
DB00224The metabolism of Indinavir can be increased when combined with Fluocortolone.
DB00227The metabolism of Lovastatin can be increased when combined with Fluocortolone.
DB00238The metabolism of Nevirapine can be increased when combined with Fluocortolone.
DB00250The metabolism of Dapsone can be increased when combined with Fluocortolone.
DB00281The metabolism of Lidocaine can be increased when combined with Fluocortolone.
DB00317The metabolism of Gefitinib can be increased when combined with Fluocortolone.
DB00321The metabolism of Amitriptyline can be increased when combined with Fluocortolone.
DB00333The metabolism of Methadone can be increased when combined with Fluocortolone.
DB00343The metabolism of Diltiazem can be increased when combined with Fluocortolone.
DB00401The metabolism of Nisoldipine can be increased when combined with Fluocortolone.
DB00404The metabolism of Alprazolam can be increased when combined with Fluocortolone.
DB00439The metabolism of Cerivastatin can be increased when combined with Fluocortolone.
DB00490The metabolism of Buspirone can be increased when combined with Fluocortolone.
DB00497The metabolism of Oxycodone can be increased when combined with Fluocortolone.
DB00499The metabolism of Flutamide can be increased when combined with Fluocortolone.
DB00514The metabolism of Dextromethorphan can be increased when combined with Fluocortolone.
DB00528The metabolism of Lercanidipine can be increased when combined with Fluocortolone.
DB00557The metabolism of Hydroxyzine can be increased when combined with Fluocortolone.
DB00571The metabolism of Propranolol can be increased when combined with Fluocortolone.
DB00608The metabolism of Chloroquine can be increased when combined with Fluocortolone.
DB00641The metabolism of Simvastatin can be increased when combined with Fluocortolone.
DB00655The metabolism of Estrone can be increased when combined with Fluocortolone.
DB00656The metabolism of Trazodone can be increased when combined with Fluocortolone.
DB00661The metabolism of Verapamil can be increased when combined with Fluocortolone.
DB00673The metabolism of Aprepitant can be increased when combined with Fluocortolone.
DB00683The metabolism of Midazolam can be increased when combined with Fluocortolone.
DB00700The metabolism of Eplerenone can be increased when combined with Fluocortolone.
DB00701The metabolism of Amprenavir can be increased when combined with Fluocortolone.
DB00714The metabolism of Apomorphine can be increased when combined with Fluocortolone.
DB00734The metabolism of Risperidone can be increased when combined with Fluocortolone.
DB00741The metabolism of Hydrocortisone can be increased when combined with Fluocortolone.
DB00758The metabolism of Clopidogrel can be increased when combined with Fluocortolone.
DB00802The metabolism of Alfentanil can be increased when combined with Fluocortolone.
DB00813The metabolism of Fentanyl can be increased when combined with Fluocortolone.
DB00820The metabolism of Tadalafil can be increased when combined with Fluocortolone.
DB00822The metabolism of Disulfiram can be increased when combined with Fluocortolone.
DB00829The metabolism of Diazepam can be increased when combined with Fluocortolone.
DB00862The metabolism of Vardenafil can be increased when combined with Fluocortolone.
DB00897The metabolism of Triazolam can be increased when combined with Fluocortolone.
DB00904The metabolism of Ondansetron can be increased when combined with Fluocortolone.
DB00909The metabolism of Zonisamide can be increased when combined with Fluocortolone.
DB00916The metabolism of Metronidazole can be increased when combined with Fluocortolone.
DB00921The metabolism of Buprenorphine can be increased when combined with Fluocortolone.
DB00962The metabolism of Zaleplon can be increased when combined with Fluocortolone.
DB00972The metabolism of Azelastine can be increased when combined with Fluocortolone.
DB00976The metabolism of Telithromycin can be increased when combined with Fluocortolone.
DB01023The metabolism of Felodipine can be increased when combined with Fluocortolone.
DB01054The metabolism of Nitrendipine can be increased when combined with Fluocortolone.
DB01058The metabolism of Praziquantel can be increased when combined with Fluocortolone.
DB01062The metabolism of Oxybutynin can be increased when combined with Fluocortolone.
DB01076The metabolism of Atorvastatin can be increased when combined with Fluocortolone.
DB01095The metabolism of Fluvastatin can be increased when combined with Fluocortolone.
DB01103The metabolism of Quinacrine can be increased when combined with Fluocortolone.
DB01114The metabolism of Chlorpheniramine can be increased when combined with Fluocortolone.
DB01115The metabolism of Nifedipine can be increased when combined with Fluocortolone.
DB01126The metabolism of Dutasteride can be increased when combined with Fluocortolone.
DB01166The metabolism of Cilostazol can be increased when combined with Fluocortolone.
DB01184The metabolism of Domperidone can be increased when combined with Fluocortolone.
DB01190The metabolism of Clindamycin can be increased when combined with Fluocortolone.
DB01211The metabolism of Clarithromycin can be increased when combined with Fluocortolone.
DB01216The metabolism of Finasteride can be increased when combined with Fluocortolone.
DB01218The metabolism of Halofantrine can be increased when combined with Fluocortolone.
DB01224The metabolism of Quetiapine can be increased when combined with Fluocortolone.
DB01232The metabolism of Saquinavir can be increased when combined with Fluocortolone.
DB01238The metabolism of Aripiprazole can be increased when combined with Fluocortolone.
DB01259The metabolism of Lapatinib can be increased when combined with Fluocortolone.
DB01267The metabolism of Paliperidone can be increased when combined with Fluocortolone.
DB04856The metabolism of Dexloxiglumide can be increased when combined with Fluocortolone.
DB04946The metabolism of Iloperidone can be increased when combined with Fluocortolone.
DB04957The metabolism of Azimilide can be increased when combined with Fluocortolone.
DB05521The metabolism of Telaprevir can be increased when combined with Fluocortolone.
DB06228The metabolism of Rivaroxaban can be increased when combined with Fluocortolone.
DB06267The metabolism of Udenafil can be increased when combined with Fluocortolone.
DB06403The metabolism of Ambrisentan can be increased when combined with Fluocortolone.
DB06419The metabolism of Cethromycin can be increased when combined with Fluocortolone.
DB06605The metabolism of Apixaban can be increased when combined with Fluocortolone.
DB06652The metabolism of Vicriviroc can be increased when combined with Fluocortolone.
DB06697The metabolism of Artemether can be increased when combined with Fluocortolone.
DB08820The metabolism of Ivacaftor can be increased when combined with Fluocortolone.
DB08873The metabolism of Boceprevir can be increased when combined with Fluocortolone.
DB08883The metabolism of Perampanel can be increased when combined with Fluocortolone.
DB08899The metabolism of Enzalutamide can be increased when combined with Fluocortolone.
DB09061The metabolism of Cannabidiol can be increased when combined with Fluocortolone.
DB09065The metabolism of Cobicistat can be increased when combined with Fluocortolone.
DB09068The metabolism of Vortioxetine can be increased when combined with Fluocortolone.
DB09102The metabolism of Daclatasvir can be increased when combined with Fluocortolone.
DB09231The metabolism of Benidipine can be increased when combined with Fluocortolone.
DB09237The metabolism of Levamlodipine can be increased when combined with Fluocortolone.
DB09297The metabolism of Paritaprevir can be increased when combined with Fluocortolone.
DB11574The metabolism of Elbasvir can be increased when combined with Fluocortolone.
DB11586The metabolism of Asunaprevir can be increased when combined with Fluocortolone.
DB11689The metabolism of Selumetinib can be increased when combined with Fluocortolone.
DB11712The metabolism of Tezacaftor can be increased when combined with Fluocortolone.
DB11737The metabolism of Icotinib can be increased when combined with Fluocortolone.
DB11757The metabolism of Istradefylline can be increased when combined with Fluocortolone.
DB11915The metabolism of Valbenazine can be increased when combined with Fluocortolone.
DB11951The metabolism of Lemborexant can be increased when combined with Fluocortolone.
DB12130The metabolism of Lorlatinib can be increased when combined with Fluocortolone.
DB12161The metabolism of Deutetrabenazine can be increased when combined with Fluocortolone.
DB12301The metabolism of Doravirine can be increased when combined with Fluocortolone.
DB13952The metabolism of Estradiol acetate can be increased when combined with Fluocortolone.
DB13955The metabolism of Estradiol dienanthate can be increased when combined with Fluocortolone.
DB14011The metabolism of Nabiximols can be increased when combined with Fluocortolone.
DB14185The metabolism of Aripiprazole lauroxil can be increased when combined with Fluocortolone.
DB14541The metabolism of Hydrocortisone cypionate can be increased when combined with Fluocortolone.
DB06448The metabolism of Lonafarnib can be increased when combined with Fluocortolone.
DB14542The metabolism of Hydrocortisone phosphate can be increased when combined with Fluocortolone.
DB09256The metabolism of Tegafur can be increased when combined with Fluocortolone.
DB00091Fluocortolone may increase the immunosuppressive activities of Cyclosporine.
DB13074The therapeutic efficacy of Macimorelin can be decreased when used in combination with Fluocortolone.
DB00381The metabolism of Amlodipine can be increased when combined with Fluocortolone.
DB00024The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluocortolone.
DB00279The therapeutic efficacy of Liothyronine can be decreased when used in combination with Fluocortolone.
DB00451The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Fluocortolone.
DB01583The therapeutic efficacy of Liotrix can be decreased when used in combination with Fluocortolone.
DB03604The therapeutic efficacy of Tiratricol can be decreased when used in combination with Fluocortolone.
DB09100The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Fluocortolone.
DB00425The metabolism of Zolpidem can be increased when combined with Fluocortolone.
DB00331The therapeutic efficacy of Metformin can be decreased when used in combination with Fluocortolone.
DB00945The risk or severity of adverse effects can be increased when Fluocortolone is combined with Acetylsalicylic acid.
DB11986The metabolism of Entrectinib can be increased when combined with Fluocortolone.
DB01432Cholestyramine may increase the excretion rate of Fluocortolone which could result in a lower serum level and potentially a reduction in efficacy.
DB00388The risk or severity of hypertension can be increased when Fluocortolone is combined with Phenylephrine.
DB00357The therapeutic efficacy of Fluocortolone can be decreased when used in combination with Aminoglutethimide.
DB01268The risk or severity of hyperglycemia can be increased when Sunitinib is combined with Fluocortolone.
DB00030The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin human.
DB00046The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin lispro.
DB00047The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin glargine.
DB00071The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin pork.
DB00197The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Troglitazone.
DB00222The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glimepiride.
DB00263The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Sulfisoxazole.
DB00280The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Disopyramide.
DB00284The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Acarbose.
DB00359The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Sulfadiazine.
DB00412The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Rosiglitazone.
DB00414The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Acetohexamide.
DB00468The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Quinine.
DB00491The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Miglitol.
DB00672The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Chlorpropamide.
DB00731The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Nateglinide.
DB00738The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Pentamidine.
DB00839The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Tolazamide.
DB00912The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Repaglinide.
DB00914The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Phenformin.
DB01016The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glyburide.
DB01067The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glipizide.
DB01120The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Gliclazide.
DB01124The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Tolbutamide.
DB01132The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Pioglitazone.
DB01251The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Gliquidone.
DB01252The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Mitiglinide.
DB01261The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Sitagliptin.
DB01276The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Exenatide.
DB01277The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Mecasermin.
DB01278The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Pramlintide.
DB01289The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glisoxepide.
DB01306The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin aspart.
DB01307The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin detemir.
DB01309The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin glulisine.
DB01382The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glymidine.
DB01700The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with AICA ribonucleotide.
DB04830The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Buformin.
DB04876The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Vildagliptin.
DB04878The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Voglibose.
DB05115The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with NN344.
DB05819The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with NBI-6024.
DB06011The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with AMG-222.
DB06127The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Bisegliptin.
DB06203The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Alogliptin.
DB06292The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Dapagliflozin.
DB06335The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Saxagliptin.
DB06655The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Liraglutide.
DB08382The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Gosogliptin.
DB08882The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Linagliptin.
DB08907The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Canagliflozin.
DB08962The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glibornuride.
DB09022The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Benfluorex.
DB09038The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Empagliflozin.
DB09043The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Albiglutide.
DB09045The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Dulaglutide.
DB09198The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Lobeglitazone.
DB09199The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Netoglitazone.
DB09200The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Rivoglitazone.
DB09201The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Ciglitazone.
DB09265The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Lixisenatide.
DB09456The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin beef.
DB09564The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin degludec.
DB11567The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin peglispro.
DB11568The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin tregopil.
DB11698The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Ipragliflozin.
DB11723The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Dutogliptin.
DB11780The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Allicin.
DB11824The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Tofogliflozin.
DB11827The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Ertugliflozin.
DB11898The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with 2,4-thiazolidinedione.
DB11950The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Teneligliptin.
DB11992The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Omarigliptin.
DB12268The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Carmegliptin.
DB12412The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Gemigliptin.
DB12417The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Anagliptin.
DB12625The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Evogliptin.
DB12713The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Sotagliflozin.
DB12781The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Balaglitazone.
DB12935The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Remogliflozin etabonate.
DB13406The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Carbutamide.
DB13446The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Guar gum.
DB13675The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Metahexamide.
DB13928The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Semaglutide.
DB14027The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Taspoglutide.
DB14035The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Englitazone.
DB15171The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Tirzepatide.
DB15217The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Gastric inhibitory polypeptide.
DB01200The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Bromocriptine.
DB00951The serum concentration of Isoniazid can be decreased when it is combined with Fluocortolone.
DB01396The risk or severity of adverse effects can be increased when Fluocortolone is combined with Digitoxin.
DB00390The risk or severity of adverse effects can be increased when Fluocortolone is combined with Digoxin.
DB00511The risk or severity of adverse effects can be increased when Fluocortolone is combined with Acetyldigitoxin.
DB01078The risk or severity of adverse effects can be increased when Fluocortolone is combined with Deslanoside.
DB13401The risk or severity of adverse effects can be increased when Fluocortolone is combined with Metildigoxin.
DB13467The risk or severity of adverse effects can be increased when Fluocortolone is combined with Lanatoside C.
DB13537The risk or severity of adverse effects can be increased when Fluocortolone is combined with Gitoformate.
DB13691The risk or severity of adverse effects can be increased when Fluocortolone is combined with Acetyldigoxin.
DB04914The therapeutic efficacy of G17DT can be decreased when used in combination with Fluocortolone.
DB05144The therapeutic efficacy of PEV3A can be decreased when used in combination with Fluocortolone.
DB05325The therapeutic efficacy of INGN 225 can be decreased when used in combination with Fluocortolone.
DB05374The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Fluocortolone.
DB05440The therapeutic efficacy of SRP 299 can be decreased when used in combination with Fluocortolone.
DB05942The therapeutic efficacy of GI-5005 can be decreased when used in combination with Fluocortolone.
DB06400The therapeutic efficacy of Vitespen can be decreased when used in combination with Fluocortolone.
DB06584The therapeutic efficacy of TG4010 can be decreased when used in combination with Fluocortolone.
DB09057The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Fluocortolone.
DB10062The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Fluocortolone.
DB10076The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Fluocortolone.
DB10276The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Fluocortolone.
DB10283The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Fluocortolone.
DB10317The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Fluocortolone.
DB10318The therapeutic efficacy of Varicella Zoster Vaccine (Live/attenuated) can be decreased when used in combination with Fluocortolone.
DB10342The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Fluocortolone.
DB10343The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Fluocortolone.
DB10583The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluocortolone.
DB10584The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluocortolone.
DB10600The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Fluocortolone.
DB10769The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Fluocortolone.
DB10794The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Fluocortolone.
DB10803The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Fluocortolone.
DB10804The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Fluocortolone.
DB10805The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Fluocortolone.
DB10989The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Fluocortolone.
DB10990The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Fluocortolone.
DB11003The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Fluocortolone.
DB11038The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Fluocortolone.
DB11040The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Fluocortolone.
DB11041The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Fluocortolone.
DB11044The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Fluocortolone.
DB11050The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Fluocortolone.
DB11603The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Fluocortolone.
DB11627The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Fluocortolone.
DB12386The therapeutic efficacy of Bacillus calmette-guerin substrain danish 1331 live antigen can be decreased when used in combination with Fluocortolone.
DB12568The therapeutic efficacy of Tecemotide can be decreased when used in combination with Fluocortolone.
DB12768The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Fluocortolone.
DB13924The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Fluocortolone.
DB14022The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Fluocortolone.
DB14384The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Fluocortolone.
DB14385The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Fluocortolone.
DB14394The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Fluocortolone.
DB14409The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Fluocortolone.
DB14443The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Fluocortolone.
DB14445The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Fluocortolone.
DB14449The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Fluocortolone.
DB14619The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Fluocortolone.
DB14620The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Fluocortolone.
DB14685The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Fluocortolone.
DB14711The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Fluocortolone.
DB15274The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Fluocortolone.
DB15461The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Fluocortolone.
DB15483The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Fluocortolone.
DB15595The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Fluocortolone.
DB15654The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Fluocortolone.
DB06119The serum concentration of Cenobamate can be decreased when it is combined with Fluocortolone.
DB01364Ephedrine may increase the excretion rate of Fluocortolone which could result in a lower serum level and potentially a reduction in efficacy.
DB00052The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluocortolone.
DB01320The serum concentration of Fosphenytoin can be decreased when it is combined with Fluocortolone.
DB00252The serum concentration of Fluocortolone can be decreased when it is combined with Phenytoin.
DB14513The serum concentration of Magnesium can be decreased when it is combined with Fluocortolone.
DB01601The serum concentration of Fluocortolone can be increased when it is combined with Lopinavir.
DB00503The serum concentration of Ritonavir can be increased when it is combined with Fluocortolone.
DB00232The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Methyclothiazide.
DB00436The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Bendroflumethiazide.
DB00562The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Benzthiazide.
DB00774The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Hydroflumethiazide.
DB00880The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Chlorothiazide.
DB00999The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Hydrochlorothiazide.
DB01021The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Trichlormethiazide.
DB01324The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Polythiazide.
DB13532The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Cyclopenthiazide.
DB00606The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Cyclothiazide.
DB13430The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Mebutizide.
DB00502The serum concentration of Haloperidol can be increased when it is combined with Fluocortolone.
DB11652The metabolism of Tucatinib can be decreased when combined with Fluocortolone.
DB12530The risk or severity of infection can be increased when Fluocortolone is combined with Inebilizumab.
DB11932The serum concentration of Fluocortolone can be increased when it is combined with Abametapir.
DB15762The serum concentration of Fluocortolone can be decreased when it is combined with Satralizumab.
DB15093The serum concentration of the active metabolites of Fluocortolone can be decreased when Fluocortolone is used in combination with Somapacitan.